US Stock MarketDetailed Quotes

GPCR Structure Therapeutics

Watchlist
  • 33.410
  • +3.310+11.00%
Close Nov 22 16:00 ET
  • 33.410
  • 0.0000.00%
Post 20:02 ET
1.91BMarket Cap-17301P/E (TTM)

Structure Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Structure Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Structure Therapeutics Earnings Reports

  • Structure Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 22:32 ET

  • Structure Therapeutics | 8-K: Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights First patients dosed in Phase 2b ACCESS study of GSBR-1290 for obesity

    Nov 13 16:17 ET

  • Structure Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:40 ET

  • Structure Therapeutics | 8-K: Structure Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

    Aug 8 16:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 9, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Weight Loss Drugs
    Weight Loss Drugs
    Intraday+1.00%
    Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-0.25%